Akebia Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA), a biopharmaceutical company dedicated to improving the lives of individuals affected by kidney disease, will participate in the 39th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for January 13, 2021, at 2:50 p.m. EST, led by John P. Butler, President and CEO. Interested parties can access the live webcast and replay on the Investors section of Akebia's website. Founded in 2007 and based in Cambridge, Massachusetts, Akebia is focused on developing therapeutics for kidney disease.

CAMBRIDGE, Mass., Jan. 4, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, President and Chief Executive Officer, will present virtually at the 39^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, at 2:50 p.m. EST.

A live webcast and replay of Akebia's presentation and associated Q&A will be available on the Investors section of the Company's website at https://ir.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-39th-annual-jp-morgan-healthcare-conference-301199899.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics present at the J.P. Morgan Healthcare Conference?

Akebia Therapeutics will present on January 13, 2021, at 2:50 p.m. EST.

Who is presenting for Akebia at the J.P. Morgan Healthcare Conference?

John P. Butler, the President and CEO of Akebia, will present.

How can I watch Akebia's presentation at the J.P. Morgan Healthcare Conference?

The presentation will be available via a live webcast on Akebia's Investors website.

What is the purpose of Akebia Therapeutics?

Akebia Therapeutics aims to improve the lives of people impacted by kidney disease.

What is the stock symbol for Akebia Therapeutics?

The stock symbol for Akebia Therapeutics is AKBA.